Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial
NCT01796678Phase 2Completed
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Start
- Sep 2000
- Primary completion
- Jun 2007
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in sickle cell disease (SCD), vaso-occlusive crisis (VOC), sponsored by UCSF Benioff Children's Hospital Oakland. Started Sep 2000; status: completed.
02
Drugs
arginine
03
Conditions
sickle cell disease (SCD)vaso-occlusive crisis (VOC)
Beyond the preview
Go deeper on NCT01796678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01796678.